Relationship of C-reactive protein with components of the metabolic syndrome in normal-weight and overweight elderly

被引:27
作者
Hoekstra, T
Geleijnse, JM
Schouten, EG
Kok, FJ
Kluft, C
机构
[1] Univ Wageningen & Res Ctr, Div Human Nutr, NL-6700 EV Wageningen, Netherlands
[2] TNO Prevent & Hlth, Gaubius Lab, Leiden, Netherlands
关键词
C-reactive protein; overweight; metabolic syndrome;
D O I
10.1016/j.numecd.2005.01.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim: C-reactive protein (CRP) is known to be elevated in the metabolic syndrome. We aimed to explore in more detail the relationship between CRP and other components of the metabolic syndrome in a general. population of 605 Dutch elderly individuals aged 65-84 years. Methods and results: Data were collected on body mass index (BMI), plasma CRP, plasma plasminogen activator inhibitor 1 (PAI-1), serum insulin, serum lipids, blood pressure, lifestyle and medical history. CRP was log-transformed (ln-CRP) to improve normality. Associations of ln-CRP with components of the metabolic syndrome were studied by multivariate linear regression analysis, in strata of gender and overweight status, with adjustment for age, physical activity, and smoking habits. A total of 322 subjects (53%) were overweight (BMI >= 25 kg/m(2)). Conclusions: In normal-weight women, ln-CRP was significantly associated with BMI, PAI-1, serum insulin, and HDL-cholesterol. In overweight women, however, these relationships were weak and not statistically significant. Findings were similar in men, although less pronounced than in women. Our data suggest that the role of CRP in the metabolic syndrome is modified by the amount of body fat. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:270 / 278
页数:9
相关论文
共 34 条
[1]   Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome [J].
Aronson, D ;
Bartha, P ;
Zinder, O ;
Kerner, A ;
Markiewicz, W ;
Avizohar, O ;
Brook, GJ ;
Levy, Y .
INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (05) :674-679
[2]   Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women [J].
Barinas-Mitchell, E ;
Cushman, M ;
Meilahn, EN ;
Tracy, RP ;
Kuller, LH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) :1094-1101
[3]  
Bastard JP, 1999, CIRCULATION, V99, P2221
[4]   Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes [J].
Birgel, M ;
Gottschling-Zeller, H ;
Röhrig, K ;
Hauner, H .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (06) :1682-1687
[5]   The central roles of obesity-associated dyslipidaemia, endothelial activation and cytokines in the Metabolic Syndrome - an analysis by structural equation modelling [J].
Chan, JCN ;
Cheung, JCK ;
Stehouwer, CDA ;
Emeis, JJ ;
Tong, PCY ;
Ko, GTC ;
Yudkin, JS .
INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (07) :994-1008
[6]   Pro-inflammatory cytokines and adipose tissue [J].
Coppack, SW .
PROCEEDINGS OF THE NUTRITION SOCIETY, 2001, 60 (03) :349-356
[7]   Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses [J].
Danesh, J ;
Whincup, P ;
Walker, M ;
Lennon, L ;
Thomson, A ;
Appleby, P ;
Gallimore, JR ;
Pepys, MB .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7255) :199-204
[8]   C-reactive protein and cardiovascular disease: a review of risk prediction and interventions [J].
de Ferranti, S ;
Rifai, N .
CLINICA CHIMICA ACTA, 2002, 317 (1-2) :1-15
[9]   Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris [J].
deMaat, MPM ;
deBart, ACW ;
Hennis, BC ;
Meijer, P ;
Havelaar, AC ;
Mulder, PGH ;
Kluft, C .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (09) :1156-1162
[10]   Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals [J].
Eriksson, P ;
Reynisdottir, S ;
Lönnqvist, F ;
Stemme, V ;
Hamsten, A ;
Arner, P .
DIABETOLOGIA, 1998, 41 (01) :65-71